News

1 to 9 of 22 results

MedImmune joins research collaboration with the University of California

MedImmune joins research collaboration with the University of California

17-02-2014

MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

Antibiotics and Infectious diseasesCardio-vascularInflammatory diseasesMedImmuneMetabolicsNeurologicalOncologyPharmaceuticalResearchRespiratory and PulmonaryUSA

Grifols gains global rights to Aradigm's Pulmaquin

23-05-2013

Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

FDA approves Novartis' TOBI Podhaler and Cangene's first Botulism Antitoxin heptavalent

24-03-2013

The US Food and Drug Administration on Friday approved Swiss drug major Novartis' (NOVN: VX) TOBI Podhaler…

Antibiotics and Infectious diseasesBotulism antitoxinCangeneNorth AmericaNovartisPharmaceuticalRegulationRespiratory and PulmonaryTobi Podhaler

FDA staffers seem to back safety of Janssen bedaquiline (Sirturo)

27-11-2012

Ahead of the November 28 meeting of the US Food and Drug Administration's Anti-Infective Drugs Advisory…

Antibiotics and Infectious diseasesbedaquilineJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySirturo

Positive Ph IIb results for Otsuka TB drug candidate delamanid

07-06-2012

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) has announced Phase IIb clinical trial results on…

Antibiotics and Infectious diseasesdelamanidOtsukaPharmaceuticalResearchRespiratory and Pulmonary

Another academia deal for Sanofi, now with Weill Cornell for tuberculosis drug discovery

01-07-2011

Paris, France-based Sanofi (Euronext: SAN) says that it entered into a research collaboration with Weill…

Antibiotics and Infectious diseasesPharmaceuticalResearchRespiratory and PulmonarySanofi

Hikma takes stake in Indian pharma company Unimark Remedies

18-04-2011

Jordan-headquartered generic drugmaker Hikma Pharmaceuticals (LSE: HIK) revealed on Friday that it has…

Antibiotics and Infectious diseasesAsia-PacificCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsRespiratory and PulmonaryUnimark Remedies

German pharma hails progress against TB and resistant bacteria

28-03-2011

Tuberculosis “is on the march worldwide,” said Siegfried Throm, director of research, development…

Antibiotics and Infectious diseasesBayerEuropePharmaceuticalResearchRespiratory and Pulmonary

1 to 9 of 22 results

COMPANY SPOTLIGHT

Menarini

Back to top